Target Details
| UniProt AC | Q14164 |
|---|---|
| Gene Symbol | IKBKE |
| Protein Name | Inhibitor of nuclear factor kappa-B kinase subunit epsilon |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) PF18394 (TBK1_CCD1) PF18396 (TBK1_ULD) |
Summary
- Multi-target molecules 596
- Clinical molecules 14
- Avg pChEMBL 7.38
KEGG Pathways (18)
- Alcoholic liver disease
- C-type lectin receptor signaling pathway
- Chemical carcinogenesis - receptor activation
- Coronavirus disease - COVID-19
- Cytosolic DNA-sensing pathway
- Epstein-Barr virus infection
- Hepatitis B
- Hepatitis C
- Herpes simplex virus 1 infection
- Human papillomavirus infection
- IL-17 signaling pathway
- Influenza A
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- NOD-like receptor signaling pathway
- RIG-I-like receptor signaling pathway
- Toll-like receptor signaling pathway
Active Molecules (596)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
SUGGCBUBUXYRSO
|
8.3 | IC50 | 3 | — | |
XKOFZEQBVZTDKP
|
8.3 | IC50 | 2 | — | |
XUELBKVSGYWSKD
|
8.3 | IC50 | 4 | — | |
ZXXUISVZQNQVSN
|
8.3 | IC50 | 2 | — | |
ZYIWBKBHSZCDAY
|
8.3 | IC50 | 3 | — | |
DTVZKOJSVBWMFX
|
8.3 | IC50 | 2 | — | |
HKSZLNNOFSGOKW
|
8.3 | Kd | 213 | — | |
CIETZITWMCYAKI
|
8.3 | IC50 | 2 | — | |
LNIQNXFRNKFXIV
|
8.3 | IC50 | 3 | — | |
GNLWUSMRXGCMEL
|
8.2 | IC50 | 2 | — | |
FVLDQJNJSJKSKE
|
8.2 | IC50 | 2 | — | |
FZHSNZZYHHRLDX
|
8.2 | IC50 | 2 | — | |
SXFYXPVAKZPFNY
|
8.2 | IC50 | 2 | — | |
AEIPIIUQGITKFW
|
8.2 | IC50 | 3 | — | |
BTBPQEMNWVDZLK
|
8.2 | IC50 | 2 | — | |
CRTQNZPWVJVSDE
|
8.2 | IC50 | 2 | — | |
HNBPCYSNJZUPBY
|
8.2 | IC50 | 2 | — | |
MLQSFEZKSQONMK
|
8.2 | IC50 | 2 | — | |
ORHHPZBLKIDTBX
|
8.2 | IC50 | 3 | — | |
SBZFMUSXXCQCBH
|
8.2 | IC50 | 2 | — | |
UONSKTNQTWRUCS
|
8.2 | IC50 | 2 | — | |
UUYGOKZIAFBEGX
|
8.2 | IC50 | 3 | — | |
WMGMGJHVTOJFFS
|
8.2 | IC50 | 2 | — | |
NRQATTKRQXGWKI
|
8.2 | IC50 | 2 | — | |
VZLQAULNDFJYPL
|
8.2 | IC50 | 2 | — | |
DPSWJWLFWZHTFD
|
8.2 | IC50 | 3 | — | |
ILMIYGFJNQSXMA
|
8.2 | IC50 | 3 | — | |
LYADGAGFYYXXIO
|
8.2 | IC50 | 82 | — | |
TVLWSLIAVPDZCA
|
8.2 | IC50 | 2 | — | |
VBVBCPLRKQJABM
|
8.2 | IC50 | 3 | — | |
VSJOESPDNYTXFI
|
8.2 | IC50 | 2 | — | |
ZJRUXNCHFMDOOM
|
8.2 | IC50 | 3 | — | |
BONUPFNAVKLWCH
|
8.1 | IC50 | 2 | — | |
BKPUHGLQZAVNHO
|
8.1 | IC50 | 2 | — | |
JSWCKNMMDIGGRJ
|
8.1 | IC50 | 2 | — | |
KLRNJRXQJGPXMS
|
8.1 | IC50 | 3 | — | |
LQABZRGBAHLOEB
|
8.1 | IC50 | 2 | — | |
PZDIPKRKYNMOJE
|
8.1 | IC50 | 2 | — | |
QELZALHAUCFZNA
|
8.1 | IC50 | 2 | — | |
QVZNMWNIVGLWCE
|
8.1 | IC50 | 2 | — | |
SMBITOOEILSWPI
|
8.1 | IC50 | 2 | — | |
XOEXSVADUVFQRN
|
8.1 | IC50 | 2 | — | |
YXLPNLVTKVQNGW
|
8.1 | IC50 | 2 | — | |
SBRWSTZGLKCGQC
|
8.1 | IC50 | 2 | — | |
ZKDPTJOJEWYFEP
|
8.1 | IC50 | 2 | — | |
QZQONLSSIXUDTB
|
8.1 | IC50 | 2 | — | |
FIISTVNCJUTUKH
|
8.1 | IC50 | 2 | — | |
FFTJPMREKVKUKF
|
8.1 | IC50 | 3 | — | |
IUDBEIQBJIEKNX
|
8.1 | IC50 | 3 | — | |
KICWLQGEPQRPSZ
|
8.1 | IC50 | 3 | — |